BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹2.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -0.06 | |
| Mar2024 | ₹18 Cr | 67.43 | |
| Mar2023 | ₹10 Cr | 69.85 | |
| Mar2022 | ₹6.17 Cr | 208.45 | |
| Mar2021 | ₹2.00 Cr | - | |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹251.9 Cr | -8.1% | -8.5% | 35.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -8.1% |
-8.5% |
35.6% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses